Clinical Trial Update: Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated medroxyprogesterone acetate for treating endometrial cancers, including endometrial adenocarcinoma and related uterine cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Adenocarcinoma
• Endometrial Adenosquamous Carcinoma
• Endometrial Cancer
• Endometrioid Endometrial Adenocarcinoma with Squamous Differentiation

Drugs mentioned

• Provera (medroxyprogesterone acetate)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-15